Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth Cancer Treatment Costs Surge Into Hundreds of Thousands ACA Could Offer Relief Survivor Suggests EU Industry Commissioner Warns Against SingleCountry Supply Chain Reliance Amid China Tensions US AI Expansion in Asia Gains Momentum Following TrumpXi Summit Innospec IOSP Rises in SmallCap Spotlight as Dividend and Buyback Program Expand Lowes Aptiv Zoetis Market Digest Highlights Mixed Sector Trends MLYS Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues BK Q1 2026 Earnings EPS Surpasses Estimates by 133 Revenue Details Not Disclosed NABL Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Gains Despite Miss CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short QNRX Q1 2026 Earnings NarrowerthanExpected Loss Despite Zero Revenue ASBA Q1 2026 Earnings EPS Slightly Beats Estimates Note Price Unchanged BioLineRx BLRX Rallies 65 as Shares Test Key Resistance Levels Buenaventura Mining BVN Surges 457 Support Holds as Precious Metals Rally American Public Education Inc APEI Gains Ground as Shares Move Toward Key Resistance Lite Strategy Inc LITS Holds Steady at 107 as Key Support and Resistance Levels Tested VirTra Inc VTSI Declines 187 as Shares Test Key Support Level Trump Reverses AI Safety Review Requirement in Executive Order Tech Industry Prevails OM Q1 2026 Earnings EPS Misses Estimates as Outset Medical Posts WiderThanExpected Loss Stock Edges Up Shift4 Payments FOUR Slides Slightly as Traders Weigh Resistance Levels ASTL Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Operational Adjustments GRBK Q1 2026 Earnings EPS Surges 15 Above Estimates ADAG Q2 2025 Earnings EPS Miss as ClinicalStage Biotech Focuses on Pipeline Advancement OPCH Q1 2026 Earnings EPS Beats Estimates by 546 Amid Revenue Data Unavailability Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges ADXN Q1 2024 Earnings PreRevenue Biotech Reports Net Loss Amid Ongoing RD Efforts